Navigation Links
Noblis Receives U.S. Patent for SNP Analysis and Genome Sequencing System and Methods
Date:4/25/2019

Noblis, Inc., a leading provider of science, technology, and strategy solutions, announces today the award of U.S. patent 10,191,929, “Systems and Methods for SNP Analysis and Genome Sequencing.” Noblis’ new system and methods make it easier, quicker, and more efficient to conduct a variety of advanced bioinformatic analyses, including SNP calling, metagenomic analysis, and conserved and signature sequence detection.

Noblis’ patented technology is the basis of BioVelocity®, a DNA alignment bioinformatics tool. Using a fast and accurate hashing algorithm, BioVelocity indexes billions of nucleotides across tens of thousands of references, or more and aligns reads to a set of references. This index is then used to align “one to many” read files.

This advancement is particularly impactful as genomic sequencing becomes increasingly less expensive and outputs continue to increase. Thus, there is a heightened need for data analysis to quickly and efficiently process genomic data.

“Noblis is proud that our proactive investment in genomic research, high performance computing, and data analytics has led to our patented BioVelocity technology, an industry leading tool that has made a tangible impact on the public heath and national security priorities of our federal clients,” Chris Barnett, Noblis Chief Technology Officer, said.

“Bioinformatics research will continue to play a major role in ensuring food safety, preventing disease, and reducing the threat of biological warfare,” Dr. Sterling Thomas, Noblis’ Defense and Homeland Security Chief Scientist, said. “As such, Noblis bioinformatics is dedicated to a steadfast investment in advancing this emerging area of research and development.”

To learn more about Noblis’ BioVelocity tool, as well as the company’s other bioinformatics tools and life science research, visit bioportal.noblis.org.

Noblis is a dynamic science, technology, and strategy organization dedicated to creating forward-thinking technical and advisory solutions in the public interest. We bring the best of scientific thought, management, and engineering expertise together in an environment of independence and objectivity to deliver enduring impact on federal missions.

Noblis works with a wide range of government clients in the defense, intelligence and federal civil sectors. Together with our wholly owned subsidiary, Noblis ESI, we tackle the nation's toughest problems and support our clients' most critical missions. Learn more at noblis.org and noblis-esi.com.

Read the full story at https://www.prweb.com/releases/noblis_receives_u_s_patent_for_snp_analysis_and_genome_sequencing_system_and_methods/prweb16266336.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Fluxion Biosciences Receives National Cancer Institute Grant for Development of ERASE-Seq Liquid Biopsy Technology
2. Catalent Receives P&G External Business Partner of the Year Award
3. rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
4. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
5. NDA Partners Expert Consultant Vinod Shah, PhD, Receives AAPS Award for Global Leadership
6. EARTHRES Vice President Louis F. Vittorio, Jr., P.G., Receives IBWA Advocacy Award
7. FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format
8. Captiva Spine Receives Clearance to Market TowerLOX-EXT MIS Extended Tab Pedicle Screw
9. EyeLock Receives Patent for Sequentially Linking Iris Matching With Facial Imaging
10. Genos receives CAP Accreditation for Meeting the Highest Standards in Laboratory Practices
11. FST Biometrics Receives a Visionary Award from Frost & Sullivan for Leading the Market in Biometrics-based In Motion Identification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2020)... ... , ... “Although we are disappointed to have to make this decision our ... public. We remain committed to creating a global platform to showcase the science, ... President of WMIS. , The abstract deadline for the virtual meeting ...
(Date:5/28/2020)... ... May 27, 2020 , ... CrucialTrak, a global designer and manufacturer ... Critical Environments Group (CEG) to market and sell its complete line of biometric ... IT environment infrastructure optimization solutions . , Brett Mason, CrucialTrak’s Director of ...
(Date:5/26/2020)... ... May 26, 2020 , ... Genedata, ... that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, including ... therapeutics, has implemented Genedata Biologics ® within their R&D organization. ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... 09, 2020 , ... Reducing carbon emissions has been and will continue to ... stock market dips, ways to reduce CO2 is something we can’t avoid. , ... the biofuels being produced today are created from recycled cooking oil or crops. Unfortunately, ...
(Date:5/28/2020)... BASEL, Switzerland (PRWEB) , ... May 28, 2020 ... ... for biopharmaceutical R&D, today announced the release of Genedata Screener ® 17.0, ... management of screening data from all in-vitro screening assay technologies. Genedata will host ...
(Date:5/21/2020)... ... May 19, 2020 , ... Eaton Square is pleased ... of Popper and Company, a biotechnology and medical technology-focused strategy and M&A advisory firm. ... in the United States, linking US and Asia Pacific healthcare innovators with capital and ...
(Date:5/15/2020)... ... ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, ... continue to lead Sentien’s Board of Directors, a role he has filled for the ... management team. , Mr. Ganz has more than 30 years of experience ...
Breaking Biology Technology: